Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-11-13
2007-11-13
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000
Reexamination Certificate
active
11261717
ABSTRACT:
The present subject matter relates to phenylurea capreomycin derivatives, and to metabolites and pharmaceutically acceptable salts and solvates thereof. The compounds of the present subject matter are useful as antibacterial agents for treating bacterial infections and for treating disorders caused by bacterial infections. The present subject matter also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial infections by administering such compounds. The present subject matter also relates to methods of preparing such compounds.
REFERENCES:
Dirlam, et al., Bioorganic and Medicinal Chemistry Letters, 1997, 7(9), 1139-1144.
R.G. Linde II, “Cyclic Homopentapeptides 3. Synthetic Modifications to the Capreomycins and Tuberactinomycins: Compounds with Activity Against Methicillin-Resistant Staphylococcus Aureus And Vancomycin-Resistant Enterococci” Bioorganic & Medical Chemistry Letters, vol. 7, Oxford, GB, 1997.
J.P. Dirlam, “Cyclic Homopentapeptides 1. Analogs of Tuberactinomycins and Capreomycin with Activity Against Vancomycin-Resistant Enterococci and Pasteurella”, Bioorganic & Medical Chemistry Letters, vol. 7, Oxford, GB, 1997.
Mu Wang, Steven J. Gould, “Biosynthesis of Capreomycin. 2. Incorporation of L-Serine, L-Alanine, and L-2,3-Diaminopropionic Acid” Journal of Organic Chemistry, vol. 58, 1993, pp. 5176-5180.
Steven J. Gould, “Biosynthesis of Capreomycin. 1. Incorporation of Arginine” Journal of Organic Chemistry, vol. 57, 1992, pp. 5214-5217.
International Preliminary Report On Patentability, date of mailing: May 18, 2007, (10 pages).
Lyssikatos Joseph P.
Wenglowsky Steven Mark
Array BioPharma Inc.
Gudibande Satyanarayana R.
Moore John R.
LandOfFree
Capreomycin derivatives and their use as antibacterials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Capreomycin derivatives and their use as antibacterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capreomycin derivatives and their use as antibacterials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3887594